En Es
Categories

CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic testing for organisms and genetic-based diseases
Products Covid-19Summary
Close

Covid-19 CEPHEID

Clinical Laboratory

SARS-CoV-2 Test
Xpert® Xpress SARS-CoV-2

The Xpert® Xpress SARS-CoV-2 is a rapid, near-patient test for the detection of the 2019 novel coronavirus that causes COVID-19 that leverages the design principles of Cepheid’s current Xpert® Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted. The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in as soon as 30 minutes for positive results with less than a minute of hands on time to prepare the sample.
More details

SARS-CoV-2/Flu/RSV Test
Xpert® Xpress SARS-CoV-2/Flu/RSV

The Xpert® Xpress SARS-CoV-2/Flu/RSV four-in-one test is expected to deliver qualitative detection of SARS-CoV-2, Flu A, Flu B and RSV from a single patient sample. The test is designed for use on any of Cepheid's more than 25,000 GeneXpert® Systems placed worldwide, with results expected in as little as 35 minutes.
More details
Close

About CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic testing for organisms and genetic-based diseases
FaceBook Twitter Google+ Linked in
Molecular Diagnostic System

Molecular Diagnostic System

Model: GeneXpert Omni
Request Information

Description:

The GeneXpert Omni point of care molecular diagnostic system leverages existing cartridge technology to deliver accuracy, speed, and ease-of-use. Advanced microfluidics regulate all aspects of the testing process within the test cartridge — from sample preparation and nucleic acid extraction, to amplification and detection.


Send A Message To This Supplier

* Required Information
* Email
To
CEPHEID (Molecular Diagnostic System)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions